Series B funding round for Blueprint Medicines raising $25M in January 2014
Series B funding round for Blueprint Medicines raising $25M in January 2014
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Venture Capital | — | |
| Private | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$115M
Top Valuation
-
Blueprint Medicines raised $25M in a Series B round.
The round was announced on 01/01/14.
The round was led by Thilo Schroeder.